Why This Landed on My Radar
I’m betting at least three patients asked you about Ozempic or Zepbound this week. And I’m guessing at least one of them came back fuming because their insurance denied coverage. This isn’t just another prior auth headache - this is becoming a daily battleground in our practices, and we need a better playbook than “sorry, insurance won’t cover it.” KFF Health News just published a patient navigation guide that’s getting circulated widely, which means our phones are about to light up with questions.
Here’s What’s Going On
The story centers on Deborah Finley, a 50-year-old California patient who finally found success with Zepbound after years of struggling with obesity, sleep apnea, nonalcoholic fatty liver disease, and prediabetes. Her pulmonologist couldn’t get bariatric surgery covered. Traditional diet and exercise weren’t working. Zepbound did - her sleep apnea improved dramatically, she lost weight. Then her insurance plan simply stopped covering GLP-1s for weight loss at the end of last year.
This is the pattern we’re all seeing. Patients meet FDA criteria for obesity treatment. They have legitimate comorbidities. The medications work. Then insurers either deny coverage outright or yank it after approval, citing formulary changes or new “medical necessity” criteria that seem designed to fail. The coverage landscape for these drugs is a moving target, with employers and insurers making monthly decisions about whether to cover them, which ones to cover, and under what impossible-to-meet conditions.
What This Means for Your Practice
Here’s our Texas problem: we already have the highest uninsured rate in the nation at about 17%, and we’re leading the country in obesity prevalence at nearly 36%. No Medicaid expansion means our lower-income patients who might benefit most from GLP-1s have no coverage path unless they’re diabetic. For those with commercial insurance, BCBS Texas and United dominate our market - and both have been tightening GLP-1 coverage aggressively.
This creates an impossible dynamic in our exam rooms. We finally have medications that work for obesity and its comorbidities. The evidence is solid. Patients see the results on social media and come in asking for them. We write the prescription… and then become the face of the denial when insurance says no. The prior auth process is eating up our staff time, the appeals rarely succeed, and patients either pay $1,000+ out of pocket monthly or they give up.
The revenue cycle impact is real too. These aren’t quick visits. Obesity medicine requires counseling time, documentation of failed interventions, careful management of side effects, and coordination with nutrition services. If we’re doing all that work and the patient can’t actually get the medication, we’ve invested significant resources with no clinical outcome and often an unhappy patient who feels we didn’t fight hard enough.
Meanwhile, the cash-pay med spa down the street is advertising compounded semaglutide and seeing patients same-day. We’re trying to practice evidence-based medicine within insurance constraints while less-regulated competitors are capturing this entire patient segment.
Key Takeaways
- GLP-1 coverage for weight loss is unstable - even patients with approval can lose coverage when plans change formularies mid-year
- Texas patient demographics make this particularly challenging - highest uninsured rate, no Medicaid expansion, and high obesity prevalence create perfect storm
- Staff time on prior auths and appeals for these drugs is substantial - track it, because it’s affecting your overhead without corresponding revenue
- Have the coverage conversation upfront - before prescribing, know what the patient’s specific plan covers and set realistic expectations
- Consider developing a systematic approach - templated documentation, coverage verification workflow, and patient financial counseling resources
What Smart Practices Are Doing
Forward-thinking practices are building GLP-1 coverage verification into their workflow before the prescribing visit, with staff checking specific formulary coverage and prior auth requirements while the patient is still in the waiting room. Some are partnering with patient assistance programs and maintaining updated lists of manufacturer savings programs, while others are offering cash-pay options with transparent pricing to compete with med spas on legitimate, non-compounded medications.
Source
“Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know” - KFF Health News
Primary Care Perspective delivers curated intelligence from trusted healthcare sources.
© 2026 Primary Care Perspective | Texas Edition